Evidence map›Paper›PMID 33187286›Full record

ArticleJournal of personalized medicine2020

Impact of Single-Nucleotide Polymorphisms of

Noelia Marquez Pete, María Del Mar Maldonado Montoro, Cristina Pérez Ramírez, Almudena Sánchez Martín, Juan Enrique Martínez de la Plata, Fernando Martínez Martínez, Rafael Caliz Caliz, Abdelali Daddaoua, María Del Carmen Ramírez Tortosa, Alberto Jiménez Morales

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Influence of theJournal of personalized medicine · 2021
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Noelia Marquez PetePharmacy Service. Pharmacogenetics Unit, University Hospital Virgen de las Nieves, Avda. Fuerzas Armadas, 2, 18014 Granada, Spain.
María Del Mar Maldonado MontoroClinical Analysis Service, Hospital Campus de la Salud, Av. de la Investigación, 18016 Granada, Spain.
Cristina Pérez RamírezPharmacy Service. Pharmacogenetics Unit, University Hospital Virgen Macarena, Dr. Fedriani, 3, 41009 Sevilla, Spain.
Almudena Sánchez MartínPharmacy Service. Pharmacogenetics Unit, University Hospital Virgen de las Nieves, Avda. Fuerzas Armadas, 2, 18014 Granada, Spain.
Juan Enrique Martínez de la PlataPharmacy Service. Hospital de Poniente-El Ejido, Diseminado Ctra Almerimar, 31, 04700 El Ejido, Spain.
Fernando Martínez MartínezDepartment of Physical Chemistry, Faculty of Pharmacy, University of Granada, Campus Universitario de Cartuja, 18071 Granada, Spain.
Rafael Caliz CalizRheumatology Service, University Hospital Virgen de las Nieves, Avda. Fuerzas Armadas, 2, 18014 Granada, Spain.
Abdelali DaddaouaDepartment of Biochemistry, Faculty of Pharmacy, University of Granada, Campus Universitario de Cartuja, 18071 Granada, Spain.
María Del Carmen Ramírez TortosaDepartment of Biochemistry, Faculty of Pharmacy, University of Granada, Campus Universitario de Cartuja, 18071 Granada, Spain.
Alberto Jiménez MoralesPharmacy Service. Pharmacogenetics Unit, University Hospital Virgen de las Nieves, Avda. Fuerzas Armadas, 2, 18014 Granada, Spain.
Hospital Universitario Virgen de las Nieves · ESUniversidad de Granada · ESHospital de Poniente · ESHospital Universitario Virgen Macarena · ESParque Tecnológico de la Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abatacept (ABA) is used as a first-line treatment in patients diagnosed with moderate and severe rheumatoid arthritis (RA). The interindividual response to ABA therapy is very variable in these patients. The objective of our study was therefore to investigate the role of polymorphisms of the

Indexed as

abataceptCTLA4effectivenesspolymorphismsrheumatoid arthritis

Identifiers

PMID33187286
PMCPMC7711575
OpenAlexW3098258612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.